Partnerships are the key to neglected diseases

15 Feb 2005

Scrip World Pharmaceutical News: In this second article looking at ways to stimulate R&D in neglected diseases, Mary Moran of the London School of Economics argues that public-private partnerships should be actively supported.

First published in issue 3030 of Scrip World Pharmaceutical News
Copyright T&F Informa UK Ltd 2005
Reprinted with permission of PJB Publications